Novartis India Limited (BOM:500672)
India · Delayed Price · Currency is INR 785.55
+19.15 (2.50%)
At close: Jan 22, 2026
Novartis India Market Cap
Novartis India has a market cap or net worth of 19.41 billion as of January 23, 2026. Its market cap has decreased by -12.81% in one year.
Market Cap
19.41B
Enterprise Value
13.28B
Revenue
3.55B
Ranking
n/a
PE Ratio
18.21
Stock Price
785.55
Market Cap Chart
Since April 14, 1999, Novartis India's market cap has increased from 12.59B to 19.41B, an increase of 54.23%. That is a compound annual growth rate of 1.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 19.41B | 0.92% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 31.21B |
| Unichem Laboratories | 26.52B |
| Hikal | 24.72B |
| Shukra Pharmaceuticals | 20.09B |
| Morepen Laboratories | 18.98B |
| Amrutanjan Health Care | 17.71B |
| Bliss GVS Pharma | 16.26B |
| TTK Healthcare | 14.14B |